North America Bioactive Wound Management Market to Grow at a CAGR of 7.4% to reach US$ 1,333.21 million from 2020 to 2027

North America Bioactive Wound Management Market to 2027- Covid-19 Impact and Regional Analysis by Product (Bioengineered Skin Substitutes, Collagen-based Dressing, Antimicrobial Dressings, Alginates, and Hydrocolloids) ; Application (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Surgical Wounds); End User ([Hospitals and Clinics, Ambulatory Surgical Centers, and Others)], and Country

  • Report Code : TIPRE00012096
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 116
Buy Now

The North America bioactive wound management marketis expected to reach US$ 1,333.21 million by 2027 from US$ 755.37 million in 2019; it is estimated to grow at a CAGR of 7.4% from 2020 to 2027.

Increasing incidences of wounds and ulcers, growing number of surgical procedures, and innovation in advanced wound care products are the key factors driving the growth of bioactive wound management market. However, high cost associated with superior quality wound care management and lackof reimbursement policies are the major factors hindering the market growth in North America.

The wound dressing made by using biomaterials is known as bioactive wound care dressings. These wounddressing materials are designed to be in direct contact with the injury and prevent the chances of further infection. These dressings are made up of both synthetics as well as natural polymers. The rise in diabetes cases, as well as skin injuries due to burns, is  expected to fuel the growth of the North America bioactive wound management market during the forecast  period.

Rising diabetes-associated risks such as diabetic foot ulcers and pressure sores are increasing the demand for bioactive wound care products. Additionally, factors such as antimicrobial resistance, adoption of unhealthy lifestyles, alcohol consumption, and smoking contribute to the rise in the prevalence of non-communicable diseases. As per the American Diabetes Association, in 2018, approximately 34.2 million Americans, or 10.5% of the population had diabetes, and this number is expected to reach 700 million by 2045. Moreover, complications associated with diabetes, such as diabetic foot ulcers, are also facilitating the need for advanced wound care management products. For instance, as per the International Diabetes Federation, a person with diabetes is 15–40 times more likely to require lower-leg amputation. Approximately 85% of amputations are followed by the development of a neuropathic foot ulcer.

Increasing cases of chronic wounds are driving the growth of the bioactive wound management market. Aging population and increasing cases of diabetes and obesity are the factors contributing to the rising need for wound care products. Chronic wounds are slow to heal, as per the National Institutes of Health, thishave currently affected 6.5 million people in the US. Additionally, wound care is associated with high costs and has become a significant challenge for healthcare systems. As per the National Center for Biotechnology Information, in the US, Medicare spends from US$ 28.1 to US$ 96.8 billion annually on wound treatment. The increasing economic burden demands for advanced wound management products, which in turn drives the growth of the bioactive wound management market.

The outbreak of the COVID-19 pandemic has adversely affected the non-healing or chronic wound management market. COVID-19 among older people has resulted in severe complications and has accounted for a large number of deaths in North America. Additionally,  chronic wounds or non-healing wounds are majorly seen in older people and takes a longer time to heal. Therefore, regular dressing and proper care is required to prevent chronic cases of infection and health condition. The outbreak of COVID-19 has impact bioactive wound management market profoundly by affecting the quality care. It has only affected wound care but also the entire healthcare system in the region.

Mexico Bioactive wound management Market,Revenue and Forecast to 2027 (US$ Mn)

Mexico Bioactive wound management Market,Revenue and Forecast to 2027 (US$ Mn)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

NORTH AMERICABIOACTIVE WOUND MANAGEMENT MARKET SEGMENTATION

By Product

  • Alginates
  • Collagen-based Dressing
  • Antimicrobial Dressings
  • Bioengineered Skin Substitutes
  • Hydrocolloids


By Application

  • Burn Wounds
  • Surgical Wounds
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers


By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others


By Country

  • US
  • Canada
  • Mexico


Company Profiles

  • Covalon Technologies Ltd.
  • Integra Life Sciences Corporation
  • Organogenesis Inc.
  • MiMedx
  • ETS Wound Care, LLC
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Application, End User ], and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Bioactive Wound Management Market – By Product

1.3.2 North America Bioactive Wound Management Market – By Application

1.3.3 North America Bioactive wound management Market– By End User

1.3.4 North America Bioactive Wound Management Market – By Country

2. North America Bioactive Wound Management Market Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Bioactive Wound Management Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 4.2.1 Bioactive wound management Market - North America PEST Analysis

4.3 Expert Opinion

5. North America Bioactive Wound Management Market Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Incidences of Wounds and Ulcers

5.1.2 Growing Number of Surgical Procedures

5.1.3 Innovation in Advanced Wound Care Products

5.2 Key Market Restraints

5.2.1 High Cost Associated with Superior Quality Wound Care Management

5.2.2 Lack of Reimbursement Policies

5.3 Key Market Opportunities

5.3.1 Increasing Research Activities to Introduce Novel Wound Treatments

5.4 Future Trends

5.4.1 3D Printing in Wound Care Management

5.5 Impact Analysis

6. Bioactive Wound Management Market – North America Analysis

6.1 North America Bioactive Wound Management Market Revenue Forecasts and Analysis

7. North America Bioactive wound management Market Analysis and Forecasts To 2027 – By Product

7.1 Overview

7.2 North America Bioactive Wound Management Market, By Product 2019 & 2027 (%)

7.2.1 North America Bioactive Wound Management Market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3 Alginates

7.3.1 Overview

7.3.2 North America Alginates Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Collagen-based Dressing

7.4.1 Overview

7.4.2 North America Collagen-based Dressing Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Antimicrobial Dressings

7.5.1 Overview

7.5.2 North America Antimicrobial Dressings Market Revenue and Forecast to 2027 (US$ Mn)

7.6 Bioengineered Skin Substitutes

7.6.1 Overview

7.6.2 North America Bioengineered Skin Substitutes Market Revenue and Forecast to 2027 (US$ Mn)

7.7 Hydrocolloids

7.7.1 Overview

7.7.2 North America Hydrocolloids Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Bioactive wound management Market Analysis and Forecasts To 2027 – By Application

8.1 Overview

8.2 North America Bioactive Wound Management Market, By Application 2019 & 2027 (%)

8.2.1 North America Bioactive Wound Management Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3 Pressure Ulcers

8.3.1 Overview

8.3.2 North America Pressure Ulcers Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Diabetic Foot Ulcers

8.4.1 Overview

8.4.2 North America Diabetic Foot Ulcers Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Venous Leg Ulcers

8.5.1 Overview

8.5.2 North America Venous Leg Ulcers Market Revenue and Forecast to 2027 (US$ Mn)

8.6 Burn Wounds

8.6.1 Overview

8.6.2 North America Burn Wounds Market Revenue and Forecast to 2027 (US$ Mn)

8.7 Surgical Wounds

8.7.1 Overview

8.7.2 North America Surgical Wounds Market Revenue and Forecast to 2027 (US$ Mn)

9. North America Bioactive wound management Market Analysis – By End-User

9.1 Overview

9.2 North America Bioactive wound management Market, By End-User 2019-2027 (%)

9.2.1 North America Bioactive wound management Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 North America Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 North America Ambulatory Surgical Centers Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Bioactive Wound Management Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1 North America Bioactive Wound Management Market Revenue and Forecasts To 2027

10.1.1 Overview

10.1.2 North America: Bioactive Wound Management Market - Revenue and Forecast to 2027 (USD Million)

10.1.3 North America Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4 North America Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.5 North America Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6 North America: Bioactive Wound Management Market, by Country, 2019 & 2027 (%)

10.1.7 US: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 US: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1.1 US Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.1.2 US Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.7.1.3 US Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8 Canada: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Canada: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1.1 Canada Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.1.2 Canada Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8.1.3 Canada Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9 Mexico: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 Mexico: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1.1 Mexico Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.9.1.2 Mexico Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.1.3 Mexico Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Bioactive wound management Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. COMPANY PROFILES

12.1 Covalon Technologies Ltd.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Integra Life Sciences Corporation

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Organogenesis Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 MiMedx

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 ETS Wound Care, LLC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Word Index

LIST OF TABLES

Table 1. North America Bioactive Wound Management Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2. North America Bioactive Wound Management Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3. North America Bioactive wound management Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 4. North America Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5. North America Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6. North America Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7. US Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8. US Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9. US Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13. Mexico Bioactive Wound Management Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Bioactive Wound Management Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15. Mexico Bioactive Wound Management Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16. List of Abbreviation

LIST OF FIGURES

Figure 1. Bioactive Wound Management Market Segmentation

Figure 2. North America Bioactive Wound Management Market Overview

Figure 3. The Alginates Segment Held Largest Share of Product Segment in Bioactive Wound Management Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. North America Bioactive Wound ManagementMarket - Leading Country Markets (US$ Mn)

Figure 6. Bioactive wound management Market - North America PEST Analysis

Figure 7. Bioactive wound management Market Impact Analysis of Driver and Restraints

Figure 8. North America Bioactive wound management Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. North America Bioactive Wound Management Market, By Product 2019 & 2027 (%)

Figure 10. North America Alginates Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. North America Collagen-based Dressing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. North America Antimicrobial Dressings Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. North America Bioengineered Skin Substitutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. North America Hydrocolloids Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15. North America Bioactive Wound Management Market, By Application 2019 & 2027 (%)

Figure 16. North America Pressure Ulcers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. North America Diabetic Foot Ulcers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. North America Venous Leg Ulcers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. North America Burn Wounds Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. North America Surgical Wounds Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. North America Bioactive wound management Market, by End-User 2019 & 2027 (%)

Figure 22. North America Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. North America Ambulatory Surgical Centers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. North America: Bioactive Wound Management Market, by Key Country – Revenue (2019) (USD Million)

Figure 26. North America Bioactive Wound Management Market Revenue and Forecast to 2027 (USD Million)

Figure 27. North America: Bioactive Wound Management Market, by Country, 2019 & 2027 (%)

Figure 28. US: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

Figure 29. Canada: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. Mexico: Bioactive Wound Management Market – Revenue and Forecast to 2027 (USD Million)

Figure 31. Impact of COVID-19 Pandemic in North American Country Markets

The List of Companies - North America Bioactive Wound Management Market

  1. Covalon Technologies Ltd.
  2. Integra Life Sciences Corporation
  3. Organogenesis Inc.
  4. MiMedx
  5. ETS Wound Care, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Bioactive Wound Management Market